Paul M. Bisaro

Director at Alpharma LLC

Paul M. Bisaro has served as a member of the Zoetis Board of Directors since May 2015.

Mr. Bisaro is the former Executive Chairman of Amneal Pharmaceuticals Inc., a specialty pharmaceutical company formed by the merger of Amneal Pharmaceuticals LLC and Impax Laboratories Inc., where Mr. Bisaro previously served as President and Chief Executive Officer from March 2017 to May 2018. He was the Executive Chairman of the board of directors of Allergan plc (formerly Actavis plc) from July 2014 to October 2016. Until June 2014, Mr. Bisaro served as Board Chairman, President and Chief Executive Officer of Actavis (formerly Watson Pharmaceuticals). He was appointed President, Chief Executive Officer and a member of the board of Watson Pharmaceuticals in September 2007; and later appointed Chairman of the board of Watson Pharmaceuticals in October 2013.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Alpharma LLC

mk2Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products and genetic tests and supported by a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.


Industries

Employees

1,001-5,000

Links